Carlsmed, Inc. (CARL) Stock

Healthcare · Health Information Services · Member of Other US Stocks

Carlsmed, Inc. (CARL) closed at USD 13.85 on 2026-10-14, a change of +5.6 % over the past year, with a market capitalization of USD 380.87M.

Carlsmed, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Carlsmed, Inc. key figures

Previous close

USD 13.85 (2026-10-14)

1-year change

+5.6 %

Market cap

USD 380.87M

Enterprise value

USD 313.57M

P/E ratio (trailing)

-12.92

P/E ratio (forward)

-10.11

EPS (trailing)

-1.08

EPS (forward)

-1.38

PEG ratio

n/a

Price to book

4.51

Revenue growth

56.7 %

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

13.12

Employees

127

Analyst consensus (third-party)

strong_buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Carlsmed, Inc.

Carlsmed, Inc., a commercial-stage medical technology company, designs, manufactures, and markets AI-enabled personalized spine surgery solutions. The company develops aprevo, a comprehensive technology platform for spine fusion surgery procedures. Its aprevo platform includes proprietary surgical planning software, using outcomes-based algorithms that are aided with artificial intelligence, and resulting custom-built, anatomically designed vertebral interbody implants. The company was incorporated in 2018 and is based in Carlsbad, California.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Carlsmed, Inc. and compare it with other stocks.